Skip to main content

Table 2 Germline BRCA1 and BRCA2 mutations detected in selected samples from 136 unrelated probands and clinicopathologic correlations

From: BRCA1 and BRCA2 mutations in central and southern Italian patients

Sex

Type of cancer

Family history

Gene

Exon

Codon

Nucleotide

Effect

Female

Br (26)

None

BRCA1

11

454

1479

delAG-ter454

Female

Ov (45)

Mo: Ov (57)

BRCA1

11

502

1623

5bpdel-ter505

Female

Br (64)

D: Br (24)

BRCA1

11

1254

3880

delAG-ter1265

  

D: Br (41)

     

Female

Br (38)

Fa: Ga (64)

BRCA1

5

61

300

Cys/Gly

  

Pa: Br (50)

     

Female

bil Br (40)

Mo: Br (49)

BRCA1

16

1655

5083

del19bp-ter1670

Male

Br (79)

S: Br (35)

BRCA2

11

1293

4109

TTA-TAA

  

S: Br (55)

    

(Lys-Stop)

  

S: Br (50)

     
  

S: Col (47)

     

Female

Br (55)

S: Br (49)

BRCA2

11

1370

4339

CAG-TAG

  

S: Pan (52)

    

(Glu-Stop)

  

B: Col (54)

     

Female

Br (62)

Mo: Br (59)

BRCA2

11

1629

5117

TCA-TGA

       

(Ser-Stop)

Male

Br (54)

None

BRCA2

11

1906

5950

delCT-ter1909

Female

Br (57)

S: Br (50)

BRCA2

11

2156

6696

delTC-ter2174

2Female

Br (34)

None

BRCA2

11

2156

6696

delTC-ter2174

  1. Numbers in parentheses indicate age at onset. B, brother; bil Br,bilateral breast cancer; Br, breast cancer; Col, colorectal cancer; D,daughter; Fa, father; Ga, gastric cancer; Mo, mother; Ov, ovarian cancer; Pa,paternal aunt; Pan, pancreatic cancer; S, sister.